Table of Contents Author Guidelines Submit a Manuscript
The Scientific World Journal
Volume 2014, Article ID 156464, 4 pages
http://dx.doi.org/10.1155/2014/156464
Research Article

Effects of Isotretinoin on the Platelet Counts and the Mean Platelet Volume in Patients with Acne Vulgaris

1Department of Dermatology, Konya Training and Research Hospital, Meram, Konya 42023, Turkey
2Department of Hematology, Meram Faculty of Medicine, Necmettin Erbakan University, Konya 42080, Turkey

Received 29 August 2013; Accepted 16 December 2013; Published 29 January 2014

Academic Editors: H. Fujita and G. A. Vena

Copyright © 2014 Arzu Ataseven and Aynur Ugur Bilgin. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. Healy and N. Simpson, “Acne vulgaris,” BMJ, vol. 308, pp. 831–833, 1994. View at Publisher · View at Google Scholar
  2. G. Goodman, “Acne-natural history, facts and myths,” Australian Family Physician, vol. 35, no. 8, pp. 613–616, 2006. View at Google Scholar · View at Scopus
  3. K. Abulnaja, “Oxidant/antioxidant status in obese adolescent females with acne vulgaris,” Indian Journal of Dermatology, vol. 54, no. 1, pp. 36–40, 2009. View at Publisher · View at Google Scholar · View at Scopus
  4. M.-L. Laroche, F. Macian-Montoro, L. Merle, and J.-M. Vallat, “Cerebral ischemia probably related to isotretinoin,” Annals of Pharmacotherapy, vol. 41, no. 6, pp. 1073–1076, 2007. View at Publisher · View at Google Scholar · View at Scopus
  5. H. Sarıcaoglu, S. Tunalı, S. Alpakut, B. Ergus, and K. Aydogan, “The clinical efficiancy of isotretinoin in acne vulgaris treatment: 18 month results,” Turkiye Klinikleri Journal of Dermatology, vol. 8, pp. 24–28, 1998. View at Google Scholar
  6. J. D. Bremner, K. D. Shearer, and P. J. McCaffery, “Retinoic acid and affective disorders: the evidence for an association,” Journal of Clinical Psychiatry, vol. 73, no. 1, pp. 37–50, 2012. View at Publisher · View at Google Scholar · View at Scopus
  7. M. Polat, P. Öztaş, and M. N. İlhan, “Nodulokistik akneli hastalarda sistemik isotretinoin tedavisine bağlı klinik yan etkiler ve tedavi sonuçları,” Turkiye Klinikleri Journal of Dermatology, vol. 18, pp. 72–76, 2008. View at Google Scholar
  8. A. S. Vieira, V. Beijamini, and A. C. Melchiors, “The effect of isotretinoin on triglycerides and liver aminotransferases,” Anais Brasileiros de Dermatologia, vol. 87, pp. 382–387, 2012. View at Google Scholar
  9. S. J. Friedman, “Leukopenia and neutropenia associated with isotretinoin therapy,” Archives of Dermatology, vol. 123, no. 3, pp. 293–295, 1987. View at Google Scholar · View at Scopus
  10. K. E. Moeller and S. C. Touma, “Prolonged thrombocytopenia associated with isotretinoin,” Annals of Pharmacotherapy, vol. 37, no. 11, pp. 1622–1624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  11. T. M. Johnson and R. P. Rapini, “Isotretinoin-induced thrombocytopenia,” Journal of the American Academy of Dermatology, vol. 17, no. 5, pp. 838–839, 1987. View at Google Scholar · View at Scopus
  12. A. Doshi, A. Zaheer, and M. J. Stiller, “A comparison of current acne grading systems and proposal of a novel system,” International journal of dermatology, vol. 36, no. 6, pp. 416–418, 1997. View at Google Scholar · View at Scopus
  13. A. S. Karadag, D. T. Ertugrul, and Z. Takci, “Isotretinoin modestly increases platelet count in acne patients,” The Journal of Dermatological Treatment, vol. 24, no. 2, pp. 139–140, 2013. View at Publisher · View at Google Scholar
  14. T. Jansen and P. Altmeyer, “Thrombocytosis induced by low-dose isotretinoin,” International Journal of Dermatology, vol. 39, no. 12, pp. 956–957, 2000. View at Publisher · View at Google Scholar · View at Scopus
  15. N. P. Bruno, B. E. Beacham, and J. W. Burnett, “Adverse effects of isotretinoin therapy,” Cutis, vol. 33, no. 5, pp. 484–486, 1984. View at Google Scholar
  16. C. S. Hesdorffer, M. D. Weltman, H. Raftopoulos, B. Mendelow, and W. R. Bezwoda, “Thrombocytopenia caused by isotretinoin,” South African Medical Journal, vol. 70, no. 11, pp. 705–706, 1986. View at Google Scholar · View at Scopus
  17. M. H. Aurousseau, S. Levacher, C. Beneton, M. Blaise, and J. L. Pourriat, “Transient dysfibrinogenemia and acute pancreatitis during isotretinoin therapy,” Revue de Medecine Interne, vol. 16, no. 8, pp. 622–625, 1995. View at Publisher · View at Google Scholar · View at Scopus
  18. P. Coto-Segura, C. Galache, J. Santos-Juanes, S. Mallo-García, and J. R. Curto-Iglesias, “Temporary thrombocytopenia probably induced by isotretinoin,” Actas Dermo-Sifiliograficas, vol. 99, no. 9, pp. 743–744, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. E. Yetkin, “Mean platelet volume not so far from being a routine diagnostic and prognostic measurement,” Thrombosis and Haemostasis, vol. 100, no. 1, pp. 3–4, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. Y. Park, N. Schoene, and W. Harris, “Mean platelet volume as an indicator of platelet activation: methodological issues,” Platelets, vol. 13, no. 5-6, pp. 301–306, 2002. View at Publisher · View at Google Scholar · View at Scopus
  21. C. B. Thompson and J. A. Jakubowski, “The pathophysiology and clinical relevance of platelet heterogeneity,” Blood, vol. 72, no. 1, pp. 1–8, 1988. View at Google Scholar · View at Scopus
  22. H. Şenaran, M. Ileri, A. Altinbaş et al., “Thrombopoietin and mean platelet volume in coronary artery disease,” Clinical Cardiology, vol. 24, no. 5, pp. 405–408, 2001. View at Google Scholar · View at Scopus
  23. S. R. Jackson and J. M. Carter, “Platelet volume: laboratory measurement and clinical application,” Blood Reviews, vol. 7, no. 2, pp. 104–113, 1993. View at Google Scholar · View at Scopus
  24. J. D. Bessman, P. R. Gilmer, and F. H. Gardner, “Use of mean platelet volume improves detection of platelet disorders,” Blood Cells, vol. 11, no. 1, pp. 127–135, 1985. View at Google Scholar · View at Scopus
  25. S. S. Graham, B. Traub, and I. B. Mink, “Automated platelet-sizing parameters on a normal population,” American Journal of Clinical Pathology, vol. 87, no. 3, pp. 365–369, 1987. View at Google Scholar · View at Scopus
  26. T. A. Kodiatte, T. A. Kodiatte, U. K. Manikyam et al., “Mean platelet volüme in type 2 diabetes mellitus,” Journal of Laboratory Physicians, vol. 4, no. 1, pp. 5–9, 2012. View at Publisher · View at Google Scholar
  27. G. Lippi, L. Filippozzi, G. L. Salvagno et al., “Increased mean platelet volume in patients with acute coronary syndromes,” Archives of Pathology and Laboratory Medicine, vol. 133, no. 9, pp. 1441–1443, 2009. View at Google Scholar · View at Scopus
  28. A. Sahin, M. Sahin, H. Yuksel et al., “Themean platelet volume in patients with retinal vein occlusion,” Journal of Ophthalmology, vol. 2013, Article ID 236371, 4 pages, 2013. View at Publisher · View at Google Scholar
  29. C. Becchi, M. Al Malyan, L. P. Fabbri, M. Marsili, V. Boddi, and S. Boncinelli, “Mean platelet volume trend in sepsis: is it a useful parameter?” Minerva Anestesiologica, vol. 72, no. 9, pp. 749–756, 2006. View at Google Scholar · View at Scopus
  30. K. Kario, T. Matsuo, and K. Nakao, “Cigarette smoking increases the mean platelet volume in elderly patients with risk factors for atherosclerosis,” Clinical and Laboratory Haematology, vol. 14, no. 4, pp. 281–287, 1992. View at Google Scholar · View at Scopus
  31. M. Sit, G. AktasG, E. E. Yilmaz, I. N. Hakyemez, A. Alçelik, and A. Kucukbayrak, “Platelet parameters in hepatic hydatid cysts,” International Journal of Inflammation, vol. 2013, Article ID 593273, 3 pages, 2013. View at Publisher · View at Google Scholar
  32. C. Camisa, B. Eisenstat, A. Ragaz, and G. Weissmann, “The effects of retinoids on neutrophil functions in vitro,” Journal of the American Academy of Dermatology, vol. 6, no. 4, pp. 620–629, 1982. View at Google Scholar · View at Scopus
  33. P. D. Pigatto, A. Fioroni, and F. Riva, “Effects of isotretinoin on the neutrophil chemotaxis in cystic acne,” Dermatologica, vol. 167, no. 1, pp. 16–18, 1983. View at Google Scholar · View at Scopus
  34. G. Michaelsson, A. Vahlquist, and H. Mobacken, “Changes in laboratory variables induced by isotretinoin treatment of acne,” Acta Dermato-Venereologica, vol. 66, no. 2, pp. 144–148, 1986. View at Google Scholar · View at Scopus
  35. H. Mutlu, V. Berk, H. Karaca, A. Erden, T. Aslan, and Z. Akca, “Treatment regimen with bevacizumab decreases mean platelet volume in patients with metastatic colon cancer,” Clinical and Applied Thrombosis/Hemostasis, vol. 18, pp. 546–548, 2012. View at Google Scholar
  36. I. A. Jagroop and D. P. Mikhailidis, “Angiotensin II can induce and potentiate shape change in human platelets: effect of losartan,” Journal of Human Hypertension, vol. 14, no. 9, pp. 581–585, 2000. View at Google Scholar · View at Scopus
  37. A. Schäfer, U. Flierl, C. Vogt et al., “Telmisartan improves vascular function and reduces platelet activation in rats with streptozotocin-induced diabetes mellitus,” Pharmacological Research, vol. 56, no. 3, pp. 217–223, 2007. View at Publisher · View at Google Scholar · View at Scopus
  38. T. Gomi, T. Ikeda, Y. Shibuya, and R. Nagao, “Effects of antihypertensive treatment on platelet function in essential hypertension,” Hypertension Research, vol. 23, no. 6, pp. 567–572, 2000. View at Google Scholar · View at Scopus
  39. I. Dolasik, S. Y. Sener, K. Celebi, Z. M. Aydin, U. Korkmaz, and Z. Canturk, “The effect of metformin on mean platelet volume in diabetic patients,” Platelets, vol. 24, pp. 118–121, 2013. View at Google Scholar
  40. P. Lanzkowsky, Disorders of Platelets. Manual of Pediatric Hematology and Oncology, Elsevier Academic Press, 4th edition, 2005.